Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00182871 · ClinicalTrials.gov registry record · Phase 4
Testosterone Effects on Bone and Frailty
A Phase 4 study, sponsored by National Institute on Aging (NIA).
- Completed
- Registry status
- Phase 4
- Development phase
- 140
- Enrollment target
NCT00182871 is a Phase 4 study that has completed, run by National Institute on Aging (NIA). The registered enrollment target is 140 participants.
The verdict
NCT00182871, a Phase 4 study, has completed, sponsored by National Institute on Aging (NIA).
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 140 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the effects of testosterone replacement on bone density, muscle strength, physical performance, quality of life and prostate symptoms in men selected for low bone mineral density or fracture and some aspect of frailty.
Interventions
- DRUG testosterone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 140 participants |
| Start Date | 2001-11 |
| Est. Completion | 2007-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00182871
The ClinicalTrials.gov registry entry for NCT00182871 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 140 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute on Aging (NIA), which has 131 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which testosterone is the first listed.
NCT00182871 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00182871 about?
NCT00182871 is a clinical study titled "Testosterone Effects on Bone and Frailty". The purpose of this study is to assess the effects of testosterone replacement on bone density, muscle strength, physical performance, quality of life and prostate symptoms in men selected for low bone mineral density or fracture and some aspect of frailty.
What is the current status of trial NCT00182871?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 140 participants. The study started on 2001-11. Estimated completion is 2007-07.
What interventions are being tested in trial NCT00182871?
The interventions under investigation include: testosterone (DRUG).
Who is sponsoring clinical trial NCT00182871?
This trial is sponsored by National Institute on Aging (NIA), which has 131 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.